BIOMAT Database Logo BIOMAT Database Logo

Photoselective vaporization versus transurethral resection of the prostate for benign prostatic hyperplasia: a meta-analysis. 2012

Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
Department of First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu, China.

OBJECTIVE To determine whether photoselective vaporization has advantages over transurethral resection of the prostate (TURP) in terms of effectiveness and safety for treatment of patients with benign prostatic hyperplasia. METHODS MEDLINE, EMBASE, and the Cochrane Controlled Trial Register were searched for randomized controlled trials. The risk ratio, mean difference, and their corresponding 95% confidence intervals were calculated for dichotomous and continuous outcomes, respectively. Risk of bias of enrolled trials was assessed according to Cochrane Handbook. RESULTS A total of five trials were enrolled. There was no significant difference in the International Prostate Symptom Score and maximum flow rate between photoselective vaporization and TURP at 6-, 12-, and 24-month follow-up. Photoselective vaporization was associated with significantly lower risk of capsule perforation, transurethral resection syndrome, and clot retention, significantly lower transfusion requirements, a shorter catheterization time, and a shorter length of hospital stay. TURP was associated with a shorter operative time and a lower risk of reoperation. In addition, there was no difference in risk of acute urinary retention and urethral/bladder neck sclerosis between photoselective vaporization and TURP. CONCLUSIONS Photoselective vaporization and TURP provide comparable improvements in functional results, including International Prostate Symptom Score and maximum flow rate at 6-, 12-, and 24-month follow-up. Photoselective vaporization offers advantages over TURP in terms of intraoperative safety; however, TURP is found to have a shorter operative time and lower reoperative risk.

UI MeSH Term Description Entries
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical
D017594 Publication Bias The influence of study results on the chances of publication and the tendency of investigators, reviewers, and editors to submit or accept manuscripts for publication based on the direction or strength of the study findings. Publication bias has an impact on the interpretation of clinical trials and meta-analyses. Bias can be minimized by insistence by editors on high-quality research, thorough literature reviews, acknowledgement of conflicts of interest, modification of peer review practices, etc. Bias, Publication

Related Publications

Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
January 2014, The Journal of urology,
Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
Bipolar transurethral enucleation of prostate versus photoselective vaporization for symptomatic benign prostatic hyperplasia (>70 ml).
January 2017, Asian journal of andrology,
Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
Cost analysis of Greenlight photoselective vaporization of the prostate compared to transurethral resection of the prostate for benign prostatic hyperplasia.
December 2018, Canadian Urological Association journal = Journal de l'Association des urologues du Canada,
Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
Photoselective vaporization for benign prostatic hyperplasia.
December 2006, Issues in emerging health technologies,
Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
Photoselective vaporization of the prostate for treating benign prostatic hyperplasia.
September 2011, Expert review of medical devices,
Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
Incidence of Surgical Reintervention for Benign Prostatic Hyperplasia Following Prostatic Urethral Lift, Transurethral Resection of the Prostate, and Photoselective Vaporization of the Prostate: A TriNetX Analysis.
January 2024, European urology open science,
Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
Photoselective vaporization of the prostate with GreenLight 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis of randomized controlled trials.
February 2016, Lasers in medical science,
Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.
April 2010, The Journal of urology,
Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
Photoselective vaporization of the prostate to manage benign prostatic hyperplasia.
September 2008, Journal of endourology,
Xiaolong Zhang, and Jiang Geng, and Junhua Zheng, and Bo Peng, and Jianping Che, and Chang Liang
[A comparative study on the photoselective vaporization of the prostate and transurethral electrovaporization resection of prostate for the treatment of benign prostatic hyperplasia].
July 2007, Zhonghua wai ke za zhi [Chinese journal of surgery],
Copied contents to your clipboard!